Androgen Receptor and TGFbeta1/Smad Signaling are Mutually Inhibitory in Prostate Cancer

AR overexpression is an effective way of hormone refractory prostate cancer cells to overcome the growth inhibitory effects of elevated serum TGFbeta1 levels even in the absence of DHT. These findings provide an explanation for how AR overexpression favors growth in HRPC.